Predict your next investment

Venture Capital
lapamcapital.com

See what CB Insights has to offer

Investments

49

Portfolio Exits

7

About Lapam Capital

Lapam Capital (龙磐资本 / 北京龙磐投资管理咨询中心) is a healthcare-focused venture capital firm targeting early stage and fast-growing opportunities.

Lapam Capital Headquarter Location

B1704, Investment Plaza No. 27, Financial Street, Xicheng District

Beijing, Beijing, 100033,

China

+86-10-5288-6712

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Lapam Capital News

China Deal Monitor: Sinovation co-leads $32m funding in Hugo and more updates

Sep 29, 2020

ResearchPremium Microbial testing services provider Hugo Biotech has raised 218 million yuan ($32 million) in its Series A round jointly led by Kai-Fu Lee’s Sinovation Ventures and Beijing-based private equity firm Lapam Capital. Continue reading this report with a DSA Research and Analytics subscription. Contact us for corporate subscriptions at subs@dealstreetasia.com . Sign up for our newsletter - The Daily Brief Opt out of receiving The Daily Brief in your inbox everyday REGISTER stories_left_placeholderYou have one free story left this month.You have stories_left_placeholder free stories left this month.This is your last free story of the month. Register to continue reading our free content. × We will never share your information with third parties. If you don’t already have an account click the button below to create your account. Join DealstreetAsia's premium subscription service Unlock your competitive advantage in a rapidly evolving landscape. Our packages come with exclusive access to archive content, data, discount on summit tickets & more. Be a part of our growing community now. Singapore Reporter/s In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must. Following vacancies can be applied for (only in Singapore). Following vacancies can be applied for (only in Singapore). A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion. A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia. Singapore Reporter/s In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must. Following vacancies can be applied for (only in Singapore). Following vacancies can be applied for (only in Singapore). A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion. A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.

Lapam Capital Investments

49 Investments

Lapam Capital has made 49 investments. Their latest investment was in BridGene Biosciences as part of their Series B on July 7, 2022.

CBI Logo

Lapam Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/27/2022

Series B

BridGene Biosciences

$38.5M

Yes

1

4/8/2022

Seed VC - IV

BroadenBio

No

1

4/1/2022

Seed VC - II

Pleryon Therapeutics

$15.7M

Yes

1

3/30/2022

Series A

Subscribe to see more

Subscribe to see more

10

3/18/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/27/2022

4/8/2022

4/1/2022

3/30/2022

3/18/2022

Round

Series B

Seed VC - IV

Seed VC - II

Series A

Series A

Company

BridGene Biosciences

BroadenBio

Pleryon Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$38.5M

$15.7M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

Lapam Capital Portfolio Exits

7 Portfolio Exits

Lapam Capital has 7 portfolio exits. Their latest portfolio exit was Asieris Pharma on January 07, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/7/2022

IPO

$99M

Public

1

12/10/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

11/5/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

3/19/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

11/9/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/7/2022

12/10/2021

11/5/2021

3/19/2021

11/9/2020

Exit

IPO

IPO

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.